Inventor · disambiguated record
Rajendra Pradhan
Also filed as: PRADHAN RAJENDRA · PRADHAN RAJENDRA S
5 granted patents·8 pending applications·8 citations·filing 2007–2025
69Inventor score
Top patents by PatentIndex Score
13 records- 0188US12128101B2Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)ALEXION PHARMA INC·Filed 2018·Granted Oct 29, 2024·5 cites·12 claims
- 0285US11229686B2Reduced frequency dosage regimens for tissue non-specific alkaline phosphatase (TNSALP)-enzyme replacement therapy of hypophosphatasiaALEXION PHARMA INC·Filed 2016·Granted Jan 25, 2022·3 cites·16 claims
- 0376US2025127892A1Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) and atypical hemolytic uremic syndrome (ahus)ALEXION PHARMA INC·Filed 2024·Application pending·0 cites
- 0463US12240893B2Subcutaneous dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH)ALEXION PHARMA INC·Filed 2019·Granted Mar 4, 2025·0 cites·19 claims
- 0563US2025144208A1Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) and atypical hemolytic uremic syndrome (ahus)ALEXION PHARMA INC·Filed 2025·Application pending·0 cites
- 0652US2025145700A1Subcutaneous dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh)ALEXION PHARMA INC·Filed 2025·Application pending·0 cites
- 0748US2008070917A1Methods for administering levosimendanTHAKKAR ROOPAL B·Filed 2007·Application pending·0 cites
- 0848US2009203709A1Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase InhibitorABBOTT LAB·Filed 2009·Application pending·0 cites
- 0948US2023235035A1Dosage and administration of anti-c5 antibodies for treating paroxysmal nocturnal hemoglobinuria (pnh) in pediatric patientsALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 1045US2021388070A1Co-administration of a hyaluronidase and anti-c5 antibody for treatment of complement-associated conditionsALEXION PHARMA INC·Filed 2019·Application pending·0 cites
- 1143US12404320B2Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) in pediatric patientsALEXION PHARMA INC·Filed 2019·Granted Sep 2, 2025·0 cites·12 claims
- 1242US12460012B2Dosage and administration of anti-C5 antibodies for treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patientsALEXION PHARMA INC·Filed 2019·Granted Nov 4, 2025·0 cites·15 claims
- 1338US2022235121A1Dosage and administration of anti-c5 antibodies for treatment of atypical hemolytic uremic syndrome (ahus)ALEXION PHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rajendra Pradhan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →